BIEI - Premier Biomedical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0020
-0.0002 (-9.09%)
As of 3:14PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0022
Open0.0022
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0018 - 0.0022
52 Week Range0.0018 - 0.1550
Volume5,551,255
Avg. Volume3,942,215
Market Cap30,831
Beta (3Y Monthly)2.61
PE Ratio (TTM)N/A
EPS (TTM)-0.1630
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile

    Premier Biomedical, Inc. CEO, William Hartman, Addresses Current Challenges with The Stock Day Podcast

    Phoenix, Arizona--(Newsfile Corp. - October 21, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William Hartman, joined Stock Day host Everett Jolly. Jolly began the interview by noting that the Company's stock has been struggling, and asked Hartman to give listeners an update on ...

  • Largest Insider Trades of the Week
    GuruFocus.com

    Largest Insider Trades of the Week

    Insiders pile on shares of Kraft Heinz, shed Overstock Continue reading...

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 9/20

    HOLLYWOOD, CA / ACCESSWIRE / September 20, 2019 / Hemp cigarettes, public company audits, CBD in China, pain relief patches, Belize tree plantation, news media irresponsibility; this week on MoneyTV with ...

  • Newsfile

    Premier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction Patch(TM)

    Phoenix, Arizona--(Newsfile Corp. - September 17, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William A. Hartman, joined Stock Day host Everett Jolly. Jolly began the interview by noting that a Co-Founder of the Company, Dr. Mitchell Felder, has purchased two million shares of ...

  • Newsfile

    CEO, William Hartman, Joins The Stock Day Podcast to Discuss Their New Joint Venture and Upcoming Anti-Addiction Patch

    Phoenix, Arizona--(Newsfile Corp. - August 12, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William Hartman, joined Stock Day host Everett Jolly. To begin the interview, Jolly commented on the Company's recent announcements and asked for an update on their current projects. Hartman explained ...

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 8/9

    HOLLYWOOD, CA / ACCESSWIRE / August 9, 2019 / CBD industry, water solutions, China, identity theft; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program ...

  • ACCESSWIRE

    Premier Biomedical Signs Joint Venture Agreement With New Earth Development, RushNet Inc., and XYZ Hemp, Inc. to Market New Anti-Addiction Patch

    JACKSON CENTER, PA / ACCESSWIRE / July 30, 2019 / Premier Biomedical, Inc. (OTCQB: BIEI) announced today the signing of an agreement forming a joint venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc. to manufacture, market and sell a revolutionary Anti-Addiction Patch containing Premier Biomedical’s patented natural and synthetic formulation. The product will be based on the topical pain relieving patch technology currently marketed by Premier Biomedical. Dr. Mitchell Felder, Chairman of the Board of Premier Biomedical, stated, “The Anti-Addiction Patch is a proprietary blend of natural components, including hemp oil extracts and a patented combination (US Pat.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 5/24

    HOLLYWOOD, CA / ACCESSWIRE / May 24, 2019 / Burgeoning CBD industry, Chinese investors, solar power, water industry, beware Biden's hands; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 4/5

    HOLLYWOOD, CA / ACCESSWIRE / April 5, 2019 / NASDAQ listing, self-driving cars, computer chip recycling, water industry disruption, CBD business, $30 million spending; this week on MoneyTV with Donald ...

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 2/22

    HOLLYWOOD, CA / ACCESSWIRE / February 22, 2019 / Water solutions, CBD business, concealed carry, Colombian cannabis, reloadable Visa card, climate change kills rats; this week on MoneyTV with Donald Baillargeon. ...

  • GlobeNewswire

    Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects

    Uptick Newswire Stock Day Podcast welcomed Premier Biomedical, Inc. (BIEI), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William A. Hartman, joined Stock Day host Everett Jolly. Jolly began the interview by asking Hartman to give an update to listeners about the Company’s current projects.

  • GlobeNewswire

    Uptick Newswire Hosts the CEO of Premier Biomedical, Inc. to Talk About Exciting Deals on the Horizon with Distributors and the Launch of New Products in 2019

    Uptick Newswire Stock Day Podcast features Premier Biomedical, Inc. (OTCQB: BIEI) (“Company”), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases, which has expanded into topical hemp oil pain relief products. CEO and President, William Hartman, was welcomed back to Stock Day by Everett Jolly. Hartman started off by saying they were excited about the passage of the 2018 Farm Bill, which removes doubts surrounding the legality of hemp products.

  • ACCESSWIRE

    Premier Biomedical Signs Agreement With CBD HEMP Distributing Company to Distribute Premier’s Topical Pain Relief Products In Four Northeastern States

    JACKSON CENTER, PA / ACCESSWIRE / December 6, 2018 / Premier Biomedical, Inc (OTC: BIEI) a research based publicly traded biomedical company has signed a sales and distribution agreement with CBD Hemp Distributing Company, a newly formed company part of a conglomerate.The company, whose members have an extensive network of sales contacts in the retail pharmaceutical and pain management medical industry, will have exclusive distribution rights to Premier Biomedical's topical pain relief products in four Northeastern States of the U.S.This move augments the growing number of regional sales representatives and local distributors Premier Biomedical has scattered throughout the country. Ralph Blundo and Ron Patrick, principals in CBD HEMP DISTRIBUTING COMPANY are excited about the opportunity to distribute the high quality CBD products designed by Premier Biomedical.

  • ACCESSWIRE

    Premier Biomedical, Inc. CEO Letter - October, 2018

    An anticipated boost to CBD topical products is expected upon passage of the pending Senate Bill #S-2667, which clarifies hemp derived CBD as federally legal and acceptable for use in certain medical applications.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 10/26

    LOS ANGELES, CA / ACCESSWIRE / October 26, 2018 / Crowdfunding, cannabis payments, disruptive water company, CBD pain relief, protecting consumers, new civil war; this week on MoneyTV with Donald Baillargeon. ...